These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6198105)

  • 1. Macrophage depletion and manipulation of enhanced immune response in an animal model of bladder cancer.
    Droller MJ; Gomolka D
    Cell Immunol; 1984 Feb; 83(2):433-41. PubMed ID: 6198105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of stimulatory effects of poly(I:C) on natural cytotoxicity by anti-interferon.
    Droller MJ; Gomolka D
    Cell Immunol; 1984 Jun; 86(1):242-50. PubMed ID: 6722894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon induction and prostaglandin synthetase inhibition in the in vitro and in vivo manipulation of immune response expression in an animal model of bladder cancer.
    Droller MJ; Gomolka D
    Cell Immunol; 1982 Sep; 72(1):1-13. PubMed ID: 6184169
    [No Abstract]   [Full Text] [Related]  

  • 4. Indomethacin and poly I:C in the inhibition of carcinogen-induced bladder cancer in an experimental animal model.
    Droller MJ; Gomolka D
    J Urol; 1984 Jun; 131(6):1212-7. PubMed ID: 6202890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective immunosuppression in mice of natural killer cell activity by ochratoxin A.
    Luster MI; Germolec DR; Burleson GR; Jameson CW; Ackermann MF; Lamm KR; Hayes HT
    Cancer Res; 1987 May; 47(9):2259-63. PubMed ID: 2436759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of macrophages in the augementation of mouse natural killer cell activity by poly I:C and interferon.
    Djeu JY; Heinbaugh JA; Holden HT; Herberman RB
    J Immunol; 1979 Jan; 122(1):182-8. PubMed ID: 216746
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferon.
    Seaman WE; Merigan TC; Talal N
    J Immunol; 1979 Dec; 123(6):2903-5. PubMed ID: 227961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for the macrophage in in vivo and in vitro resistance to murine bladder tumor cell growth.
    Droller MJ; Remington JS
    Cancer Res; 1975 Jan; 35(1):49-53. PubMed ID: 1109796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of tumor burden on the modulation of natural killer cell activity.
    Morales A; Pang AS
    J Urol; 1984 Jun; 131(6):1229-31. PubMed ID: 6726932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of macrophage in in vitro augmentation of rat, mouse, and human natural killer activities.
    Reynolds CW; Brunda MJ; Holden HT; Herberman RB
    J Natl Cancer Inst; 1981 May; 66(5):837-42. PubMed ID: 6164813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective depletion of NK cell activity in vivo and its effect on the growth of NK-sensitive and NK-resistant tumor cell variants.
    Kawase I; Urdal DL; Brooks CG; Henney CS
    Int J Cancer; 1982 May; 29(5):567-74. PubMed ID: 7095901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of PSK on interferon production in tumor-bearing mice.
    Kitani H; Tsuru S; Oguchi M; Watanabe M; Zinnaka Y
    J Clin Lab Immunol; 1984 Dec; 15(4):211-4. PubMed ID: 6084715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of natural killer cell activity of thoracic duct lymphocytes by polyinosinic-polycytidylic acid (poly(I:C)) or interferon.
    Fresa KL; Korngold R; Murasko DM
    Cell Immunol; 1985 Apr; 91(2):336-43. PubMed ID: 2581698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity.
    Boraschi D; Soldateschi D; Tagliabue A
    Eur J Immunol; 1982 Apr; 12(4):320-6. PubMed ID: 6178603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the activity of mouse natural killer cells by urethan.
    Gorelik E; Herberman RB
    J Natl Cancer Inst; 1981 Mar; 66(3):543-8. PubMed ID: 6937709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible macrophage cytotoxins. I. Biokinetics of activation and release in vitro.
    Reidarson TH; Levy WE; Klostergaard J; Granger GA
    J Natl Cancer Inst; 1982 Oct; 69(4):879-87. PubMed ID: 6956764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell activity associated with reticulum cell neoplasms.
    Chang KS; Log T
    Int J Cancer; 1980 Mar; 25(3):405-16. PubMed ID: 6248470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol decreases natural killer cell activation but only minimally affects anatomical distribution after administration of polyinosinic:polycytidylic acid: role in resistance to B16F10 melanoma.
    Hébert P; Pruett SB
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1622-31. PubMed ID: 14574233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
    J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bone marrow transplantation and polyinosinic-polycytidylic acid (poly I:C) on the rescue of animals from busulfan-induced NK suppression.
    Bhoopalam N; Fried W; Benson D; Barone-Verales J; Price K
    Exp Hematol; 1989 May; 17(4):357-63. PubMed ID: 2651135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.